Comparison of a duplex quantitative real-time PCR assay and the COBAS amplicor CMV monitor test for detection of cytomegalovirus

被引:33
作者
Herrmann, B
Larsson, VC
Rubin, CJ
Sund, F
Eriksson, BM
Arvidson, J
Yun, ZB
Bondeson, K
Blomberg, J
机构
[1] Uppsala Univ, Dept Med Sci, Sect Virol, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden
[3] Uppsala Univ, Dept Womens & Childrens Hlth, Sect Pediat, Uppsala, Sweden
[4] Huddinge Univ Hosp, Dept Clin Virol, Stockholm, Sweden
关键词
D O I
10.1128/JCM.42.5.1909-1914.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A duplex quantitative real-time PCR (qPCR) assay was designed to detect both the polymerase gene (pol) and the glycoprotein gene (gB) of cytomegalovirus (CMV). The detection limit of the qPCR was determined to be 1 to 3 copies/reaction and the linear measure interval was 10(3) to 10(8) copies/ml. The qPCR system was compared to the COBAS Amplicor CMV Monitor test (COBAS) by an analysis of 138 plasma samples. Both systems detected CMV in 71 cases and had negative results for 33 samples. In addition, 34 samples were positive by qPCR and negative by the COBAS assay, but in no case was the COBAS result positive and the qPCR result negative. Thus, qPCR detected 48% more positive cases than the COBAS method. For samples with greater than or equal to10(5) copies/ml by qPCR, a saturation effect was seen in the COBAS assay and quantification required dilution. Copy numbers for pol and gB by qPCR generally agreed. However, the reproducibility of qPCR assays and the need for an international standard are discussed. Discrepant copy numbers for pol and gB by qPCR were found for samples from two patients, and sequence analysis revealed that the corresponding CMV strains were mismatched at four nucleotide positions compared with the gB fragment primer sequences. In conclusion, a duplex qPCR assay in a real-time format facilitates quantitative measurements and minimizes the risk of false-negative results.
引用
收藏
页码:1909 / 1914
页数:6
相关论文
共 28 条
[1]   Quantitation of cytomegalovirus: Methodologic aspects and clinical applications [J].
Boeckh, M ;
Boivin, G .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :533-+
[2]   QUANTITATION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-H GENE IN CELLS USING COMPETITIVE PCR AND A RAPID FLUORESCENCE-BASED DETECTION SYSTEM [J].
BOIVIN, G ;
OLSON, CA ;
QUIRK, MR ;
STCYR, SM ;
JORDAN, MC .
JOURNAL OF VIROLOGICAL METHODS, 1995, 51 (2-3) :329-342
[3]   CYTOMEGALOVIRUS DNA DETECTION OF AN IMMEDIATE EARLY PROTEIN GENE WITH NESTED PRIMER OLIGONUCLEOTIDES [J].
BRYTTING, M ;
SUNDQVIST, VA ;
STALHANDSKE, P ;
LINDE, A ;
WAHREN, B .
JOURNAL OF VIROLOGICAL METHODS, 1991, 32 (2-3) :127-138
[4]   Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma [J].
Caliendo, AM ;
Schuurman, R ;
Yen-Lieberman, B ;
Spector, SA ;
Andersen, J ;
Manjiry, R ;
Crumpacker, C ;
Lurain, NS ;
Erice, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1334-1338
[5]   COMPARATIVE-ANALYSIS OF SEQUENCE VARIATION IN GP116 AND GP55 COMPONENTS OF GLYCOPROTEIN-B OF HUMAN CYTOMEGALOVIRUS [J].
CHOU, SW .
VIROLOGY, 1992, 188 (01) :388-390
[6]   DETECTION OF HUMAN CYTOMEGALOVIRUS ANTIGENEMIA - A RAPID DIAGNOSTIC-TECHNIQUE FOR PREDICTING CYTOMEGALOVIRUS-INFECTION PNEUMONITIS IN LUNG AND HEART-TRANSPLANT RECIPIENTS [J].
EGAN, JJ ;
BARBER, L ;
LOMAX, J ;
FOX, A ;
YONAN, N ;
RAHMAN, AN ;
CAMPBELL, CS ;
DEIRANIYA, AK ;
CARROLL, KB ;
CRASKE, J ;
TURNER, A ;
WOODCOCK, AA .
THORAX, 1995, 50 (01) :9-13
[7]   Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation [J].
Emery, VC ;
Sabin, CA ;
Cope, AV ;
Gor, D ;
Hassan-Walker, AF ;
Griffiths, PD .
LANCET, 2000, 355 (9220) :2032-2036
[8]   QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS DNA USING THE POLYMERASE CHAIN-REACTION [J].
FOX, JC ;
GRIFFITHS, PD ;
EMERY, VC .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2405-2408
[9]   MONITORING OF HUMAN CYTOMEGALOVIRUS INFECTIONS AND GANCICLOVIR TREATMENT IN HEART-TRANSPLANT RECIPIENTS BY DETERMINATION OF VIREMIA, ANTIGENEMIA, AND DNAEMIA [J].
GERNA, G ;
ZIPETO, D ;
PAREA, M ;
REVELLO, MG ;
SILINI, E ;
PERCIVALLE, E ;
ZAVATTONI, M ;
GROSSI, P ;
MILANESI, G .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03) :488-498
[10]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607